Indirect Comparison Analysis to Evaluate the Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus Other Treatments for HER2-Positive Metastatic Breast Cancer (MBC)
Abstract
Authors
E. Benito Garcia V. Hersberger S. Takyar A. Moser